free article: PMC1860679](/pmc/articles/PMC1860679/)\] \[[PubMed: 16698841](https://pubmed.ncbi.nlm.nih.gov/16698841)\] 44. Luckenbill KN, Christenson RH, Jaffe AS, Mair J, Ordonez-Llanos J, Pagani F, Tate J, Wu AH, Ler R, Apple FS. Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. Clin Chem. 2008 Mar;54(3):619-21. \[[PubMed: 18310156](https://pubmed.ncbi.nlm.nih.gov/18310156)\] 45. Clerico A, Fontana M, Zyw L, Passino C, Emdin M. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clin Chem. 2007 May;53(5):813-22. \[[PubMed: 17384013](https://pubmed.ncbi.nlm.nih.gov/17384013)\] 46. Zhang ZL, Li R, Yang FY, Xi L. Natriuretic peptide family as diagnostic/prognostic biomarker and treatment modality in management of adult and geriatric patients with heart failure: remaining issues and challenges. J Geriatr Cardiol. 2018 Aug;15(8):540-546. \[[PMC free article: PMC6188938](/pmc/articles/PMC6188938/)\] \[[PubMed: 30344534](https://pubmed.ncbi.nlm.nih.gov/30344534)\] 47. Saenger AK, Rodriguez-Fraga O, Ler R, Ordonez-Llanos J, Jaffe AS, Goetze JP, Apple FS. Specificity of B-Type Natriuretic Peptide Assays: Cross-Reactivity with Different BNP, NT-proBNP, and proBNP Peptides. Clin Chem. 2017 Jan;63(1):351-358. \[[PubMed: 28062628](https://pubmed.ncbi.nlm.nih.gov/28062628)\] 48. Christ M, Mueller C. Use of natriuretic peptide assay in dyspnea. Dtsch Arztebl Int. 2008 Feb;105(6):95-100. \[[PMC free article: PMC2696716](/pmc/articles/PMC2696716/)\] \[[PubMed: 19633758](https://pubmed.ncbi.nlm.nih.gov/19633758)\] 49. Pfister R, Schneider CA. Natriuretic peptides BNP and NT-pro-BNP: established laboratory markers in clinical practice or just perspectives? Clin Chim Acta. 2004 Nov;349(1-2):25-38. \[[PubMed: 15469852](https://pubmed.ncbi.nlm.nih.gov/15469852)\] 50. Horio T, Shimada K, Kohno M, Yoshimura T, Kawarabayashi T, Yasunari K, Murakawa K, Yokokawa K, Ikeda M, Fukui T. Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. Am Heart J. 1993 Aug;126(2):293-9. \[[PubMed: 8337997](https://pubmed.ncbi.nlm.nih.gov/8337997)\] 51. Arakawa N, Nakamura M, Aoki H, Hiramori K. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology. 1994;85(5):334-40. \[[PubMed: 7850823](https://pubmed.ncbi.nlm.nih.gov/7850823)\] 52. Ozturk TC, Unluer E, Denizbasi A, Guneysel O, Onur O. Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room? J Res Med Sci. 2011 Dec;16(12):1564-71. \[[PMC free article: PMC3434897](/pmc/articles/PMC3434897/)\] \[[PubMed: 22973364](https://pubmed.ncbi.nlm.nih.gov/22973364)\] 53. Wang K, Ojamaa K, Samuels A, Gilani N, Zhang K, An S, Zhang Y, Tang YD, Askari B, Gerdes AM. BNP as a New Biomarker of Cardiac Thyroid Hormone Function. Front Physiol. 2020;11:729. \[[PMC free article: PMC7363952](/pmc/articles/PMC7363952/)\] \[[PubMed: 32733267](https://pubmed.ncbi.nlm.nih.gov/32733267)\] 54. Francis GS, Felker GM, Tang WH. A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure. J